Your browser doesn't support javascript.
loading
New 1,2,4-oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity.
Frejat, Firas O A; Cao, Yaquan; Wang, Lihong; Zhai, Hongjin; Abdelazeem, Ahmed H; Gomaa, Hesham A M; Youssif, Bahaa G M; Wu, Chunli.
Afiliação
  • Frejat FOA; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
  • Cao Y; Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Zhengzhou, People's Republic of China.
  • Wang L; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
  • Zhai H; Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Zhengzhou, People's Republic of China.
  • Abdelazeem AH; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
  • Gomaa HAM; Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Zhengzhou, People's Republic of China.
  • Youssif BGM; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
  • Wu C; Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Zhengzhou, People's Republic of China.
Arch Pharm (Weinheim) ; 355(7): e2100516, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35363388

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Topoisomerase IV / Inibidores da Topoisomerase II Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: DNA Topoisomerase IV / Inibidores da Topoisomerase II Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2022 Tipo de documento: Article